As a "precision tool" in the field of modern medical imaging diagnosis, PETCT (Positron Emission Tomography-Computed Tomography) relies on the functional metabolic imaging advantage of PET and the anatomical localization advantage of CT to play an irreplaceable role in the diagnosis of malignant tumors, cardiovascular and cerebrovascular diseases, etc. The realization of all this precise imaging is inseparable from the strong support of the core component —— scintillation crystals (such as BGO/LaBr₃:Ce/LYSO) . As a professional manufacturer of scintillation crystal materials, Leading Crystal has deeply cultivated this field and helped the iterative upgrading of PETCT technology.
The core of PETCT's imaging principle is to detect gamma rays generated by the decay of imaging agents and reconstruct three-dimensional images through computer processing. The key link in this detection process is the participation of scintillation crystals. As a core component of PETCT detectors, scintillation crystals are used in conjunction with photoelectric sensors. Their core function is to efficiently convert the detected gamma rays into identifiable photon signals, which are then converted into electrical signals, providing clear and accurate original data support for subsequent image reconstruction.
The performance of scintillation crystals directly determines the diagnostic accuracy and efficiency of PETCT. The scintillation crystals developed and produced by Leading Crystal, with excellent characteristics such as high density, high light output and short decay time, can efficiently absorb gamma rays and quickly convert signals, effectively improving the sensitivity, spatial resolution and time resolution of PETCT detectors, reducing signal interference, making the location, scope, metabolic status and other information of lesions more clearly distinguishable, helping doctors achieve early precise diagnosis and providing a reliable basis for clinical treatment.
From the perspective of industry development, the popularization and upgrading of PETCT technology have put forward higher requirements for the performance of scintillation crystals. Adhering to the market demand-oriented approach, Leading Crystal focuses on the R&D and innovation of scintillation crystal materials, optimizes product processes and improves product systems. The produced scintillation crystals are compatible with various PETCT equipment, can meet the application needs of different clinical scenarios, fill the gaps in industry technology, and promote the coordinated development of scintillation crystal materials and PETCT technology.
In the future, Leading Crystal will continue to deeply cultivate the field of scintillation crystals, increase R&D investment, break through core technological bottlenecks, continuously improve product performance and quality, empower the innovation of PETCT medical imaging technology with high-quality scintillation crystal materials, help the high-quality development of precision medical care, and guard human health with professional strength.
Your message must be between 20-3,000 characters!
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
